Yufen Chen1 and Todd B Parrish1
1Radiology, Northwestern University, Chicago, IL, United States
Synopsis
In clinical settings, dynamic susceptibility
contrast (DSC) and dynamic contrast enhanced (DCE) data are rarely acquired
together as both require a full single dose for optimal contrast-to-noise-ratio
(CNR). However, both techniques offer complementary information that aid in the
assessment of tumors. Current double acquisition methods acquire the DCE scan
first with a half dose to minimize leakage effects in the subsequent DSC scan,
compromising both scans. Here, we demonstrate the feasibility of an
automatically switching DSC-DCE scan sequence by monitoring the signal
intensity of the DSC scan, allowing acquisition of both datasets with a single
contrast dose.Purpose
Automatic acquisition of both DSC and DCE data with
a single dose of MR contrast.
Methods
Images were acquired in 3 patients on a 1.5T Siemens
Espree scanner. Prior to contrast injection, gradient echo images for intrinsic
T1 mapping utilized in DCE quantification were acquired at flip angles 2°,
7°,
10°,
15°
and 25°
with 10 dynamic scans each and 2 averages (see below for other parameters). A
baseline DCE acquisition at 12° was also acquired. The DSC images were
acquired using gradient-echo echo planar imaging (GR-EPI) with TR/TE=1500ms/35ms,
resolution=2.1x2.1mm2, 13 slices of 5mm thickness (2.5mm gap), 50
dynamic scans. 0.1mmol/kg body weight of gadolinium was injected during the 8th
dynamic scan. This was followed by the T1-weighted gradient echo DCE scan with
the following parameters: TR/TE 3.9/1.5ms, flip angle=12°,
resolution=1.8x0.9mm2, 26 slices of 3mm thickness, 80 dynamic scans.
The innovation implemented was signal surveillance
during the DSC acquisition to indicate when to switch from the DSC to the DCE
scan. The DSC sequence was modified to receive real time feedback from the
image reconstruction environment (ICE), which monitors the derivative of the
global signal intensity of an imaging slice. The first 10 images were used to generate the
baseline mean and standard deviation of the derivative. The following time
points were determined in real time:
1) Start
of first bolus passage (iStart): when the derivative of the signal is smaller
than baseline mean - 3x baseline standard deviation
2) Minimum
point (iMinimum): when the derivative becomes positive after iStart
3) Stop
point (iStop): Either when the derivative becomes negative after iMinimum or
when the number of time points exceeds iMinimum+3x(iMinimum-iStart). The second
condition provides a strict stop point in the event of severe T2
leakage effects where the signal remains close to iMinimum. This criterion is
based on previous findings in 24 tumor patients1.
Once
iStop is defined, a feedback signal is sent to stop the DSC acquisition and
automatically start the DCE acquisition. The scanner operator does not have to
do anything except start the contrast injection.
Results
The sequence successfully switched from the DSC
acquisition at the stop point to the DCE scan without manual intervention in
all subjects. The DSC global bolus plot with iStart, iMinimum and iStop
(highlighted in red) detected by the sequence is shown in Figure 1. Figure 2 shows
the concatenated timecourses of the pre-contrast gradient echo scan (blue), the
DSC scan (green) and the DCE scan (purple) extracted from regions of interest
placed in the low grade tumor (red) and healthy tissue (yellow). The DSC and
post contrast DCE signals were scaled to match the precontrast signal level to
illustrate the acquisition details. Notice the similarity between the DSC
timecourses of healthy tissue and global bolus plot, demonstrating the proposed
monitoring methodology’s insensitivity to leakage effects in DSC.
Discussion
In this study, we demonstrate the feasibility of
automatically switching from DSC to DCE acquisition with a single contrast dose
using real-time monitoring of the global signal intensity of the DSC data
acquisition. Although the data presented were acquired at 1.5T, the technique
is not limited by field strength. The DSC scan provides an estimate of the
arterial input function, which is critical for both DSC and DCE quantification.
Currently the vendor quantification package for DCE uses an assumed arterial
input function (AIF) for different flow situations. The preceding DSC scan in
our proposed method provides a patient-specific AIF that will improve the
accuracy of the DCE quantification process. Another feature of the proposed
technique is its relative insensitivity to leakage effects as the DSC stop
criterion is based on signal intensity from an entire slice. Even if the tumor
region suffers from severe leakage effects, the mean slice signal should be
minimally affected by the tumor, allowing the algorithm to successfully capture
the entire AIF. In the rare situation when the algorithm fails, the built-in hard
stop timepoint ensures that the DCE scan will not be delayed significantly.
Future efforts will focus on automating the combined analysis of both datasets
immediately after data acquisition with minimal operator intervention and
incorporating more advanced modeling to correct for leakage effects in the DSC
data.
Conclusion
We have successfully demonstrated the feasibility of
an automatically switching DSC-DCE scan sequence that allows optimal
acquisition of both types of data using a single full-dose of contrast.
Acknowledgements
The authors wish to acknowledge Dr. Haris Saybasili for helpful discussions in implementing this technique.References
1. Parrish T CG, Varadheeswaran J, Wang
X, Chen Y. Measurement of perfusion and permeability using a single full dose
contrast injection. Proceedings of the
Organization of Human Brain Mapping 2014